Group 6 Copy 101
-1
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Do turtles have enough variation in adaptive genes to keep pace with climate change?

    Climate change is expected to have impacts on biodiversity worldwide. Many species will be faced with a choice...

    Micrographic study of thylacine hair (Thylacinus cynocephalus)

    Existing papers describing the hair structure of the thylacine (also known as Tasmanian tiger, Thylacinus cynocephalus...

    Backer Badge Funded

    A biology project funded by 47 people